TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Some, like TM6SF2, previously known to function in type 2 diabetes and non‐alcoholic fatty liver disease (NAFLD),46 have been implicated in insulin resistance (TG:HDL) in this study, providing further evidence regarding insulin sensitivity during diabetes in the Indian population.